Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “breast cancer”

Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN)Recruiting
NCT07779135N/AUpdated Aug 21, 2026
Sponsor: Centre Hospitalier de Colmar
Breast Cancer · Neuropathic Pain in Cancer
France
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Recruiting
NCT06841354Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Triple Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +29 more
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsRecruiting
NCT07623369Phase 1Updated Aug 21, 2026
Sponsor: Huahui Health
Solid Tumor · Non-small Cell Lung Cancer · Hepatocellular Carcinoma · Colorectal Cancer
Australia, China
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesRecruiting
NCT06764940Phase 2Updated Aug 21, 2026
Sponsor: Biostar Pharma, Inc.
HER2-negative Breast Cancer Patients With Brain Metastases
United States
Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BCCompleted
NCT03417544Phase 2Updated Aug 21, 2026
Sponsor: Nancy Lin, MD
HER2-positive Metastatic Breast Cancer · Central Nervous System Metastases
United States
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low TrialRecruiting
NCT07391774Phase 3Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8 · Anatomic Stage IIIC Breast Cancer AJCC v8 · Estrogen Receptor-Positive Breast Carcinoma
United States, Puerto Rico
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)Recruiting
NCT06393374Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Triple-Negative Breast Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2Completed
NCT06384417NAUpdated Aug 21, 2026
Sponsor: Milton S. Hershey Medical Center
Breast Cancer · Lung Cancer · Genito-Urinary Cancer · Colorectal Cancer
United States
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer PatientsActive Not Recruiting
NCT05226078NAUpdated Aug 21, 2026
Sponsor: Abramson Cancer Center at Penn Medicine
Chronic Insomnia · Cancer-related Problem/Condition · Cancer-Related Syndrome
United States
Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.Active Not Recruiting
NCT05038735Phase 3Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Breast Cancer
Belgium, Bulgaria, Canada, Czechia, Denmark +12 more
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive Not Recruiting
NCT04147494EARLY_Phase 1Updated Aug 21, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Breast Carcinoma · Colon Carcinoma · Esophageal Carcinoma · Gastric Carcinoma
United States
A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid TumorsActive Not Recruiting
NCT05593094Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Hoffmann-La Roche
Advanced Solid Tumors · HER2-positive Breast Cancer
United States, Australia, France, Italy, New Zealand +2 more
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Recruiting
NCT07174336Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Breast Neoplasms · Neoplasm Metastasis
United States, Argentina, Australia, Belgium, Brazil +14 more
Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND TrialTerminated
NCT06643455NAUpdated Aug 20, 2026
Sponsor: Fred Hutchinson Cancer Center
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8
United States
Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast CancerCompleted
NCT07216274NAUpdated Aug 20, 2026
Sponsor: Mayo Clinic
Breast Carcinoma
United States
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase InhibitorsRecruiting
NCT05590949N/AUpdated Aug 20, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Breast Cancer
United States
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsCompleted
NCT04902872Phase 1, Phase 2Updated Aug 20, 2026
Sponsor: Cybrexa Therapeutics
Solid Tumor, Adult · Epithelial Ovarian Cancer · Small Cell Lung Carcinoma · Breast Cancer
United States
Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer SurvivorsActive Not Recruiting
NCT01450020NAUpdated Aug 20, 2026
Sponsor: City of Hope Medical Center
Breast Cancer
United States
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast CancerActive Not Recruiting
NCT05870579Phase 1Updated Aug 20, 2026
Sponsor: Novartis Pharmaceuticals
Breast Cancer
United States, China, France, Germany, Poland +2 more
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)Recruiting
NCT06103864Phase 3Updated Aug 20, 2026
Sponsor: AstraZeneca
Breast Cancer
United States, Argentina, Australia, Brazil, Canada +19 more
HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast CancerTerminated
NCT06595563Phase 2Updated Aug 20, 2026
Sponsor: Jules Bordet Institute
HER2-positive Metastatic Breast Cancer · HER2-positive Advanced Breast Cancer
Belgium, Netherlands
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerActive Not Recruiting
NCT04673448Phase 1Updated Aug 20, 2026
Sponsor: University of Washington
Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · BRCA-Associated Malignant Neoplasm · BRCA Hereditary Ovarian Carcinoma
United States
Nurturing Exercise Routine for Greater Improvement in Zest and Energy on EnhertuRecruiting
NCT07203378Phase 2Updated Aug 20, 2026
Sponsor: University of Utah
Metastatic Breast Cancer
United States
MADRE (Mammograms Available Due to Research and Education)Active Not Recruiting
NCT05841355NAUpdated Aug 20, 2026
Sponsor: University of Illinois at Chicago
Breast Cancer Screening
United States
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.Recruiting
NCT06382948Phase 3Updated Aug 20, 2026
Sponsor: MedSIR
Advanced Breast Cancer · ER-positive Breast Cancer · HER2-negative Breast Cancer · ESR1 Gene Mutation
Austria, Brazil, Czechia, France, Germany +4 more

Previous page Next page